(19)
(11) EP 4 493 151 A2

(12)

(88) Date of publication A3:
26.10.2023

(43) Date of publication:
22.01.2025 Bulletin 2025/04

(21) Application number: 23710760.2

(22) Date of filing: 14.03.2023
(51) International Patent Classification (IPC): 
A61K 9/00(2006.01)
A61K 31/05(2006.01)
A61K 31/192(2006.01)
A61K 31/216(2006.01)
A61K 31/4184(2006.01)
A61K 31/44(2006.01)
A61K 31/502(2006.01)
A61K 31/553(2006.01)
A61K 9/107(2006.01)
A61K 31/12(2006.01)
A61K 31/196(2006.01)
A61K 31/4025(2006.01)
A61K 31/436(2006.01)
A61K 31/4453(2006.01)
A61K 31/5377(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 9/145; A61K 9/148; A61K 9/5123; A61K 31/496; A61K 31/502; A61K 45/00
(86) International application number:
PCT/EP2023/056506
(87) International publication number:
WO 2023/174948 (21.09.2023 Gazette 2023/38)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 14.03.2022 US 202263269330 P
28.03.2022 WO PCT/EP2022/058180

(71) Applicant: TRX Biosciences Limited
London EC4N 8AF (GB)

(72) Inventors:
  • GOODING, Daniel
    London EC4N 8AF (GB)
  • BREW, John
    London EC4N 8AF (GB)
  • BANNISTER, Robin M.
    London EC4N 8AF (GB)

(74) Representative: Schlich 
9 St Catherine's Road Littlehampton
West Sussex BN17 5HS
West Sussex BN17 5HS (GB)

   


(54) COMPOSITIONS HAVING IMPROVED BIOAVAILABILITY OF THERAPEUTICS AND USES THEREOF